In conclusion, both resveratrol and didox synergistically interact with herceptin in T47D and MCF-7 breast cancer cell lines and this synergism is not restricted to HER-2 overexpressing breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.